| Mr Michael Andrew Roth, CAA | |
|
201 Nw R D Mize Rd, Blue Springs, MO 64014-2513 | |
| (816) 228-5900 | |
| Not Available |
| Full Name | Mr Michael Andrew Roth |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 7 Years |
| Location | 201 Nw R D Mize Rd, Blue Springs, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255860029 | NPI | - | NPPES |
| 58303041 | Other | MO | BCBS KC |
| P02320854 | Other | MO | RAILROAD |
| 1255860029 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 2017017852 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uf Health Shands Hospital | Gainesville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Clinical Practice Association | 0345146254 | 1636 |
News Archive
AstraZeneca has taken a small step in reducing the need for traditional animal testing by signing on to evaluate Organs-on-Chips from the Wyss Institute for Biologically Inspired Engineering at Harvard.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Cobroxin, an over-the-counter (OTC) treatment for stage 2 (moderate to severe) chronic pain.
Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.
The 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research will be presented to James P. Allison, PhD, at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
› Verified 5 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
AstraZeneca has taken a small step in reducing the need for traditional animal testing by signing on to evaluate Organs-on-Chips from the Wyss Institute for Biologically Inspired Engineering at Harvard.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Cobroxin, an over-the-counter (OTC) treatment for stage 2 (moderate to severe) chronic pain.
Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.
The 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research will be presented to James P. Allison, PhD, at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Andrew Roth, CAA 3645 Nw Blue Jacket Dr, Lees Summit, MO 64064-3017 Ph: () - | Mr Michael Andrew Roth, CAA 201 Nw R D Mize Rd, Blue Springs, MO 64014-2513 Ph: (816) 228-5900 |
News Archive
AstraZeneca has taken a small step in reducing the need for traditional animal testing by signing on to evaluate Organs-on-Chips from the Wyss Institute for Biologically Inspired Engineering at Harvard.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Cobroxin, an over-the-counter (OTC) treatment for stage 2 (moderate to severe) chronic pain.
Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.
The 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research will be presented to James P. Allison, PhD, at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
› Verified 5 days ago